Know Cancer

or
forgot password

Evaluation of the Use of Human Papillomavirus Persistence for Determination of the Treatment Efficacy Among Women With Cervical Intraepithelial Neoplasia, and for Prediction of Recurrence of Cervical Disease


N/A
N/A
N/A
Not Enrolling
Female
Human Papillomavirus Infection, Cervical Intraepithelial Neoplasia

Thank you

Trial Information

Evaluation of the Use of Human Papillomavirus Persistence for Determination of the Treatment Efficacy Among Women With Cervical Intraepithelial Neoplasia, and for Prediction of Recurrence of Cervical Disease


Cervical samples for human papillomavirus (HPV) DNA analysis and cytological analysis were
obtained from women with abnormal smears referred to Umeå university hospital, Sweden, for
treatment with conization. These women were scheduled for HPV DNA testing and Pap smears
before and 3, 6, 12, 24 and 36 months after treatment. The HPV DNA testing was performed
with a PCR-based genotyping method.


Inclusion Criteria:



- Referral to Umeå university hospital for treatment due to abnormal Pap smear.

Exclusion Criteria:

- Lack of informed consent.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Anna Söderlund Strand, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Dept. medical microbiology, Malmö university hospital, Malmö, Sweden

Authority:

Sweden: Institutional Review Board

Study ID:

95-240

NCT ID:

NCT00931190

Start Date:

February 2001

Completion Date:

November 2005

Related Keywords:

  • Human Papillomavirus Infection
  • Cervical Intraepithelial Neoplasia
  • Neoplasms
  • Cervical Intraepithelial Neoplasia
  • Warts
  • Carcinoma in Situ
  • Papillomavirus Infections

Name

Location